Furthermore, knockdown of GSK3β abolished the inhibitory effects of MYH9 depletion on HCC stemness, migration, invasion, proliferation, and sorafenib resistance (Supplementary Fig. 1d–g). The gene discussed is GSK3B; the disease is hepatocellular carcinoma.